CA943125A - Cyclic acetal derivatives of pregnane and process for preparation thereof - Google Patents

Cyclic acetal derivatives of pregnane and process for preparation thereof

Info

Publication number
CA943125A
CA943125A CA076,271A CA76271A CA943125A CA 943125 A CA943125 A CA 943125A CA 76271 A CA76271 A CA 76271A CA 943125 A CA943125 A CA 943125A
Authority
CA
Canada
Prior art keywords
pregnane
preparation
cyclic acetal
acetal derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA076,271A
Other languages
English (en)
Inventor
Jacques R. Boissier
Roger Ratouis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA943125A publication Critical patent/CA943125A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA076,271A 1969-03-21 1970-03-02 Cyclic acetal derivatives of pregnane and process for preparation thereof Expired CA943125A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6908232A FR2035777A1 (de) 1969-03-21 1969-03-21

Publications (1)

Publication Number Publication Date
CA943125A true CA943125A (en) 1974-03-05

Family

ID=9031031

Family Applications (1)

Application Number Title Priority Date Filing Date
CA076,271A Expired CA943125A (en) 1969-03-21 1970-03-02 Cyclic acetal derivatives of pregnane and process for preparation thereof

Country Status (11)

Country Link
US (1) US3651049A (de)
BE (1) BE747714A (de)
CA (1) CA943125A (de)
DE (1) DE2010722C3 (de)
ES (1) ES376501A1 (de)
FI (1) FI47353C (de)
FR (1) FR2035777A1 (de)
GB (1) GB1286198A (de)
NL (1) NL168843C (de)
NO (1) NO134747C (de)
SE (1) SE361474B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004249295A1 (en) * 2003-06-20 2004-12-29 Viral Genomix, Inc. Compositions for and methods for treating HIV
CN116023425B (zh) * 2023-03-28 2023-06-20 南京师范大学 曲安西龙衍生物及其医药用途

Also Published As

Publication number Publication date
FR2035777A1 (de) 1970-12-24
NL7001630A (de) 1970-09-23
NL168843B (nl) 1981-12-16
DE2010722B2 (de) 1978-11-02
FI47353C (fi) 1973-11-12
BE747714A (fr) 1970-09-21
ES376501A1 (es) 1972-04-16
DE2010722A1 (de) 1970-10-15
NO134747B (de) 1976-08-30
DE2010722C3 (de) 1979-06-21
NL168843C (nl) 1982-05-17
US3651049A (en) 1972-03-21
FI47353B (de) 1973-07-31
GB1286198A (en) 1972-08-23
SE361474B (de) 1973-11-05
NO134747C (de) 1976-12-08

Similar Documents

Publication Publication Date Title
ZA71563B (en) New pregnane derivatives and process of preparation
CA932730A (en) Dialkyl-xanthine derivatives and process of preparing the same
CA943125A (en) Cyclic acetal derivatives of pregnane and process for preparation thereof
CA994155A (en) Stable lactone solution and process for its preparation
CA966852A (en) Nickel derivatives of methylene bis-salicylic acid and process for preparing the same
AU3176271A (en) Acyl derivatives of insulin and process for their manufacture
CA946849A (en) Derivatives of d-sorbitol and process for the preparation thereof
CA963472A (en) Cycloalkano-quinolone derivatives and process for their preparation
CA942304A (en) Nitrofuryl-amidine derivatives and process for their preparation
CA845724A (en) Derivatives of alkylbenzazol and process for their preparation
IL34993A (en) 7alpha-methyl-13beta-alkyl-17beta-hydroxygona-4,11-dien-3-one and derivatives and process of preparation
CA812246A (en) 5-phosphomethyl derivatives of 6-chromanols and process for preparing same
CA808195A (en) 5-phosphomethyl derivatives of 6-chromanols and process for preparing same
AU453501B2 (en) 20-hydroxylated steroid derivatives and process of preparation
AU450992B2 (en) New pregnane derivative and process of preparation
CA829292A (en) 17-substituted progesterone derivatives and process of preparing the same
CA818491A (en) 2-carbonyl-estratrienes and method of their preparation
CA809689A (en) Pharmaceutically effective derivatives of 2-amino-indane and process for preparing them
AU2602871A (en) 20-hydroxylated steroid derivatives and process of preparation
AU440369B2 (en) New insulin derivatives and process of preparation
AU2567471A (en) New pregnane derivative and process of preparation
CA806687A (en) Derivatives of 5-methyl-oxazolidine and process for their manufacture
CA824671A (en) Glucoside derivatives and process of making same
CA966835A (en) Pyrazinylurea derivatives and process for their preparation
CA827671A (en) Adenosine derivatives and method of preparation